SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.991
AS - Asia 11.079
EU - Europa 7.386
SA - Sud America 1.749
AF - Africa 225
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 39.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.489
SG - Singapore 4.268
CN - Cina 2.666
DE - Germania 2.315
BR - Brasile 1.390
IT - Italia 1.374
VN - Vietnam 1.221
HK - Hong Kong 886
UA - Ucraina 863
GB - Regno Unito 552
RU - Federazione Russa 545
TR - Turchia 497
FI - Finlandia 476
BD - Bangladesh 383
FR - Francia 364
JP - Giappone 276
IN - India 241
SE - Svezia 240
PL - Polonia 224
CA - Canada 222
MX - Messico 196
ID - Indonesia 143
AR - Argentina 132
NL - Olanda 115
ZA - Sudafrica 88
IQ - Iraq 85
PK - Pakistan 72
ES - Italia 70
EC - Ecuador 56
CO - Colombia 45
VE - Venezuela 44
UZ - Uzbekistan 43
LT - Lituania 41
MY - Malesia 38
AT - Austria 37
BE - Belgio 37
PH - Filippine 34
SA - Arabia Saudita 31
MA - Marocco 28
AE - Emirati Arabi Uniti 24
CL - Cile 24
TN - Tunisia 21
KE - Kenya 18
AL - Albania 17
CR - Costa Rica 17
IE - Irlanda 17
JM - Giamaica 17
PE - Perù 17
AU - Australia 16
EG - Egitto 16
JO - Giordania 16
PY - Paraguay 15
NP - Nepal 14
RO - Romania 13
TH - Thailandia 13
AZ - Azerbaigian 12
BO - Bolivia 12
CH - Svizzera 12
DZ - Algeria 12
PS - Palestinian Territory 12
UY - Uruguay 12
CZ - Repubblica Ceca 10
ET - Etiopia 10
IL - Israele 10
GR - Grecia 9
KR - Corea 9
LB - Libano 9
CY - Cipro 8
KZ - Kazakistan 8
HN - Honduras 7
IR - Iran 7
LV - Lettonia 7
OM - Oman 7
PA - Panama 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
EU - Europa 6
KG - Kirghizistan 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
AM - Armenia 5
GA - Gabon 5
GT - Guatemala 5
HU - Ungheria 5
MD - Moldavia 5
MT - Malta 5
NG - Nigeria 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BY - Bielorussia 4
DK - Danimarca 4
LK - Sri Lanka 4
PR - Porto Rico 4
SV - El Salvador 4
AO - Angola 3
BG - Bulgaria 3
GE - Georgia 3
HR - Croazia 3
Totale 39.404
Salva come PNG Salva come JPEG
Città #
Singapore 2.736
Ashburn 2.168
San Jose 1.427
Woodbridge 1.317
Fairfield 1.155
Chandler 1.111
Jacksonville 906
Santa Clara 881
Hong Kong 872
Beijing 858
Houston 818
Ann Arbor 506
Seattle 445
Wilmington 443
New York 416
Ho Chi Minh City 399
Los Angeles 373
Cambridge 359
Munich 318
Dallas 312
Hanoi 296
Council Bluffs 284
Izmir 281
Nanjing 265
Tokyo 265
Princeton 227
Addison 216
Lauterbourg 215
Warsaw 215
Helsinki 196
Milan 193
São Paulo 166
San Diego 157
Shanghai 156
Ferrara 155
Mexico City 131
Boardman 116
Orem 101
Turku 91
London 90
Jakarta 89
Buffalo 87
Chicago 79
Shenyang 78
Chennai 74
Washington 72
Hebei 70
Nanchang 70
Hefei 69
Denver 68
Bremen 67
Rome 67
Toronto 67
Brooklyn 66
Montreal 65
Atlanta 60
Tianjin 58
Dearborn 56
Johannesburg 54
Changsha 52
Moscow 52
Frankfurt am Main 51
Haiphong 50
San Francisco 49
Stockholm 49
Bologna 48
Da Nang 46
Mountain View 46
Phoenix 46
Jiaxing 43
Boston 42
Manchester 40
Rio de Janeiro 40
Falls Church 37
Poplar 37
The Dalles 37
Brussels 36
Tashkent 36
Redwood City 35
Jinan 33
Kunming 33
Amsterdam 31
Guangzhou 31
Hải Dương 31
Nuremberg 30
Baghdad 29
Belo Horizonte 29
Ankara 27
Biên Hòa 27
Lahore 27
Mumbai 25
Ningbo 24
Quito 24
Norwalk 23
New Delhi 22
Zhengzhou 22
Brasília 21
Falkenstein 21
Ottawa 21
Campinas 20
Totale 24.375
Salva come PNG Salva come JPEG
Nome #
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 667
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 328
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 306
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 288
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 267
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 250
Circadian profile of plasma calcitonin gene-related peptide in healthy man 247
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 243
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 236
Pituitary and COVID-19 vaccination: a systematic review 233
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 232
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 229
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 227
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 224
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 223
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 222
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 222
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 220
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 219
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 217
Growth hormone excess promotes breast cancer chemoresistance 215
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 214
Growth hormone induces chemoresistance in breast cancer cells 214
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 212
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 209
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 207
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 205
Neck paraganglioma and follicular lymphoma: A case report 204
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 203
Antiproliferative effects of somatostatin analogs in pituitary adenomas 202
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 202
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 202
Diurnal rhythm of plasma catecholamines in acromegaly 200
Percutaneous Laser Ablation of Liver Metastases from Neuroendocrine Neoplasm. A Retrospective Study for Safety and Effectiveness 200
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 198
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 198
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 196
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
A new VHL polymorphism in a big family from Ferrara 194
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 193
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 192
A tool to predict survival in stage IV entero-pancreatic NEN 192
Efficacy, safety and adherence to treatment of teriparatide: an observational study 191
Effects of octreotide on gallbladder motor function in acromegaly 190
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 188
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 186
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 186
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 186
Growth hormone and skeletal muscle function 185
Glucose metabolism alterations in acromegaly 184
Pituitary side effects of old and new drugs. 184
In vitro testing of new somatostatin analogs on pituitary tumor cells 183
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 183
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 183
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 181
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 180
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 180
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 180
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 180
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 179
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 178
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 177
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 177
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 177
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 177
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 177
Cerebral aneurysm and acromegaly: a case report 176
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 176
ASSE GH-IGF-I NELL'INVECCHIAMENTO 175
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 175
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 174
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 174
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 173
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 173
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 173
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 172
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 172
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 172
Functional hypothalamic and drug-induced amenorrhea: an overview 172
Densitometria Ossea (DEXA): come interpretarla evitando le trappole 172
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 171
Le alterazioni pressorie nell'acromegalia: fattori umorali 168
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 166
Sistema Simpatoadrenomidollare nei pazienti acromegalici 166
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 166
Delta opioid receptor involvement in endocrine pathophysiology 165
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 165
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 164
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 163
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 163
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 163
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 162
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 162
Cerebrovascular disease and GH-IGF-i axis function 160
Real-time PCR is useful to detect menin gene deletions 159
Replacement therapy and quality of life improvement in adult GHD patients 159
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 158
Acromegaly in the elderly patients 158
Totale 19.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.919
Totale 188.672
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.981 58 208 114 57 89 90 96 90 79 162 187 751
2022/20232.357 234 221 90 310 328 341 127 205 282 26 119 74
2023/20241.350 108 142 73 41 102 263 48 150 45 30 31 317
2024/20255.557 157 149 427 183 640 580 206 198 906 687 782 642
2025/202616.268 1.472 611 1.302 1.891 2.491 1.124 1.955 910 1.486 1.783 770 473
2026/2027969 969 0 0 0 0 0 0 0 0 0 0 0
Totale 39.827